Suppr超能文献

从多特异性药物转运体-有机阴离子转运蛋白 1(Oat1)转运的靶向代谢物分析中阐明常见药效团。

Elucidation of common pharmacophores from analysis of targeted metabolites transported by the multispecific drug transporter-Organic anion transporter1 (Oat1).

机构信息

Department of Medicine, Division of Nephrology and Hypertension, University of California, San Diego, La Jolla, CA 92093, USA.

出版信息

Bioorg Med Chem. 2011 Jun 1;19(11):3320-40. doi: 10.1016/j.bmc.2011.04.045. Epub 2011 Apr 28.

Abstract

Organic anion transporter 1 (Oat1), first identified as NKT, is a multispecific transporter responsible for the handling of drugs and toxins in the kidney and choroid plexus, but its normal physiological role appears to be in small molecule metabolite regulation. Metabolites transported by Oat1 and which are altered in the blood and urine of the murine Oat1 knockout, may serve as templates for further drug design. This may lead to better tissue targeting of drugs or design of Oat1 inhibitors that prolong the half-life of current drugs. Due to the multispecificity of the transporter, 19 of known targeted metabolites have different chemical structures and properties that make constructing a common pharmacophore model difficult. Here we propose an approach that clustered the metabolites into four distinct groups which allowed for the construction of a consensus pharmacophore for each cluster. The screening of commercial molecular databases determined the top candidates whose interaction with Oat1 was confirmed in an experimental model of organic anion transport. Thus, these candidate selections represent potential molecules for further drug design.

摘要

有机阴离子转运蛋白 1(Oat1),最初被鉴定为 NKT,是一种多特异性转运蛋白,负责肾脏和脉络丛中药物和毒素的处理,但它的正常生理作用似乎在于调节小分子代谢物。Oat1 转运的代谢物以及在 Oat1 敲除小鼠的血液和尿液中改变的代谢物,可以作为进一步药物设计的模板。这可能导致药物更好地靶向组织,或者设计出延长现有药物半衰期的 Oat1 抑制剂。由于转运体的多特异性,19 种已知的靶向代谢物具有不同的化学结构和性质,这使得构建通用药效团模型变得困难。在这里,我们提出了一种将代谢物聚类成四个不同组的方法,从而可以为每个组构建共识药效团。对商业分子数据库的筛选确定了候选药物,其与 Oat1 的相互作用在有机阴离子转运的实验模型中得到了证实。因此,这些候选药物的选择代表了进一步药物设计的潜在分子。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/14a2/3310230/3102c910fc6c/nihms292559f1.jpg

相似文献

引用本文的文献

1
Small Molecule Decoys of Aggregation for Elimination of Aβ-Peptide Toxicity.小分子聚集诱饵消除 Aβ-肽毒性。
ACS Chem Neurosci. 2023 May 3;14(9):1575-1584. doi: 10.1021/acschemneuro.2c00649. Epub 2023 Apr 14.
9
What do drug transporters really do?药物转运体到底在做什么?
Nat Rev Drug Discov. 2015 Jan;14(1):29-44. doi: 10.1038/nrd4461. Epub 2014 Dec 5.

本文引用的文献

3
Interaction of organic cations with organic anion transporters.有机阳离子与有机阴离子转运体的相互作用。
J Biol Chem. 2009 Nov 6;284(45):31422-30. doi: 10.1074/jbc.M109.024489. Epub 2009 Sep 8.

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验